ArticleLeukemia2026

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

H Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.